Genomic Health
North America, California, United States, Redwood City
Description
Genomic Health is a provider of genomic-based diagnostic tests that address overtreatment and optimal treatment of early-stage cancer.
Investor Profile
Genomic Health has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 20% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series E, Series D, Series F rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.
Stage Focus
- Series E (40%)
- Series D (20%)
- Series F (20%)
- Convertible Note (20%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Health Diagnostics
- Hospital
- Precision Medicine
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
